MEIP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MEIP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, MEI Pharma's enterprise value is $-26.13 Mil. MEI Pharma's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $16.25 Mil. Therefore, MEI Pharma's EV-to-EBITDA for today is -1.61.
The historical rank and industry rank for MEI Pharma's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of MEI Pharma was 27.23. The lowest was -25.21. And the median was -1.61.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-08), MEI Pharma's stock price is $3.18. MEI Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.970. Therefore, MEI Pharma's PE Ratio for today is 1.07.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
The historical data trend for MEI Pharma's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEI Pharma Annual Data | |||||||||||||||||||||
Trend | Jun14 | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | |||||||||||
EV-to-EBITDA | Get a 7-Day Free Trial | -2.37 | -10.86 | -2.92 | 0.84 | 1.21 |
MEI Pharma Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
EV-to-EBITDA | Get a 7-Day Free Trial | 1.68 | 1.65 | 1.21 | -0.62 | -0.54 |
For the Biotechnology subindustry, MEI Pharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, MEI Pharma's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where MEI Pharma's EV-to-EBITDA falls into.
MEI Pharma's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | -26.132 | / | 16.247 | |
= | -1.61 |
MEI Pharma's current Enterprise Value is $-26.13 Mil.
MEI Pharma's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEI Pharma (NAS:MEIP) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
MEI Pharma's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 3.18 | / | 2.970 | |
= | 1.07 |
MEI Pharma's share price for today is $3.18.
MEI Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.970.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of MEI Pharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Taheer Datoo | director | 181 BAY STREET, SUITE 4200, TORONTO A6 M5J 2T3 |
James P Flynn | director | 41 HARRIS CT, DANVILLE CA 94526 |
Sujay Kango | director | 1028 CHAMBERS COURT, BRIDGEWATER NJ 08807 |
Richard G Ghalie | officer: Chief Medical Officer | C/O FAVRILLE, INC, 10445 PACIFIC CENTER COURT, SAN DIEGO CA 92121 |
Bruce Ross Winson | 10 percent owner | 5950 BERKSHIRE LANE, SUITE 510, DALLAS TX 75225 |
Anson Funds Management Lp | 10 percent owner | 16000 DALLAS PARKWAY, SUITE 800, DALLAS TX 75248 |
Anson Management Gp Llc | 10 percent owner | 16000 DALLAS PARKWAY, SUITE 800, DALLAS TX 75248 |
Anson Advisors Inc. | 10 percent owner | 155 UNIVERSITY AVENUE, SUITE 207, TORONTO A6 M5H 3B7 |
Funicular Funds, Lp | 10 percent owner | 2261 MARKET STREET, #4307, SAN FRANCISCO CA 94114 |
Amin Nathoo | 10 percent owner | 155 UNIVERSITY AVENUE, SUITE 207, TORONTO Z4 M5H 3B7 |
Moez Kassam | 10 percent owner | 111 PETER STREET, SUITE 904, TORONTO A6 M5V2H1 |
Justin J. File | officer: CFO and Corporate Secretary | C/O EVOFEM BIOSCIENCES, INC., 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO CA 92130 |
Jacob Ma-weaver | 10 percent owner | 2261 MARKET STREET, #4307, SAN FRANCISCO CA 94114 |
Cable Car Capital Llc | 10 percent owner | 2261 MARKET STREET #4307, SAN FRANCISCO CA 94114 |
Baltic Charles V. Iii | director | C/O MARSHALL EDWARDS, INC., 11975 EL CAMINO REAL, SUITE 101, SAN DIEGO CA 92130 |
From GuruFocus
By Business Wire • 07-18-2023
By Business Wire • 11-01-2023
By Business Wire • 06-27-2023
By Business Wire • 09-18-2023
By Business Wire Business Wire • 06-15-2023
By Business Wire • 12-11-2023
By Business Wire • 07-05-2023
By Business Wire • 09-21-2023
By Business Wire • 07-13-2023
By Business Wire • 07-11-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.